Willenbring H - Search Results

1

Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis.

Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, Finegold M, Grompe M. Willenbring H, et al. Cancer Cell. 2008 Jul 8;14(1):59-67. doi: 10.1016/j.ccr.2008.05.004. Cancer Cell. 2008. PMID: 18598944 Free PMC article.

2

A therapy for liver failure found in the JNK yard.

Willenbring H, Grompe M. Willenbring H, et al. Cell. 2013 Apr 11;153(2):283-4. doi: 10.1016/j.cell.2013.03.033. Cell. 2013. PMID: 23582318 Free PMC article.

3

MicroRNAs control hepatocyte proliferation during liver regeneration.

Song G, Sharma AD, Roll GR, Ng R, Lee AY, Blelloch RH, Frandsen NM, Willenbring H. Song G, et al. Among authors: willenbring h. Hepatology. 2010 May;51(5):1735-43. doi: 10.1002/hep.23547. Hepatology. 2010. PMID: 20432256 Free PMC article.

4

Therapeutic liver reconstitution with murine cells isolated long after death.

Erker L, Azuma H, Lee AY, Guo C, Orloff S, Eaton L, Benedetti E, Jensen B, Finegold M, Willenbring H, Grompe M. Erker L, et al. Among authors: willenbring h. Gastroenterology. 2010 Sep;139(3):1019-29. doi: 10.1053/j.gastro.2010.05.082. Epub 2010 Jun 2. Gastroenterology. 2010. PMID: 20621682 Free PMC article.

5

Myelomonocytic cells are sufficient for therapeutic cell fusion in liver.

Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M. Willenbring H, et al. Nat Med. 2004 Jul;10(7):744-8. doi: 10.1038/nm1062. Epub 2004 Jun 13. Nat Med. 2004. PMID: 15195088

6

Delineating the hepatocyte's hematopoietic fusion partner.

Willenbring H, Grompe M. Willenbring H, et al. Cell Cycle. 2004 Dec;3(12):1489-91. doi: 10.4161/cc.3.12.1304. Epub 2004 Dec 15. Cell Cycle. 2004. PMID: 15611666

7

Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.

Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, Okita K, Yamanaka S, Willenbring H. Espejel S, et al. Among authors: willenbring h. J Clin Invest. 2010 Sep;120(9):3120-6. doi: 10.1172/JCI43267. Epub 2010 Aug 25. J Clin Invest. 2010. PMID: 20739754 Free PMC article.

8

A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.

Mattis AN, Song G, Hitchner K, Kim RY, Lee AY, Sharma AD, Malato Y, McManus MT, Esau CC, Koller E, Koliwad S, Lim LP, Maher JJ, Raffai RL, Willenbring H. Mattis AN, et al. Among authors: willenbring h. Hepatology. 2015 Jan;61(1):141-52. doi: 10.1002/hep.27379. Epub 2014 Nov 24. Hepatology. 2015. PMID: 25131933 Free PMC article.

9

In vivo genetic selection of renal proximal tubules.

Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M. Held PK, et al. Among authors: willenbring h. Mol Ther. 2006 Jan;13(1):49-58. doi: 10.1016/j.ymthe.2005.09.004. Epub 2005 Oct 10. Mol Ther. 2006. PMID: 16216560 Free article.

10

Sustained phosphorylation of Bid is a marker for resistance to Fas-induced apoptosis during chronic liver diseases.

Vogel A, Aslan JE, Willenbring H, Klein C, Finegold M, Mount H, Thomas G, Grompe M. Vogel A, et al. Among authors: willenbring h. Gastroenterology. 2006 Jan;130(1):104-19. doi: 10.1053/j.gastro.2005.10.012. Gastroenterology. 2006. PMID: 16401474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters